Brief: Ose Immunotherapeutics Presents Clinical Abstracts On Tedopi® At ASCO 2023 Annual Meeting
06/06/2023 06:34
June 6 (Reuters) - OSE Immunotherapeutics SA OSE.PA : *Recent news on Ose Immunotherapeutics SA
See all news
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO